4/2
08:09 am
rvmd
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer [Yahoo! Finance]
Medium
Report
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer [Yahoo! Finance]
4/2
08:00 am
rvmd
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer
Medium
Report
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer
4/1
01:27 pm
rvmd
A Look At Revolution Medicines (RVMD) Valuation After Recent Share Price Momentum [Yahoo! Finance]
Low
Report
A Look At Revolution Medicines (RVMD) Valuation After Recent Share Price Momentum [Yahoo! Finance]
3/30
07:57 am
rvmd
Jefferies Highlights Revolution Medicines, Inc. (RVMD)'s RAS(ON) Platform in Coverage Initiation [Yahoo! Finance]
Low
Report
Jefferies Highlights Revolution Medicines, Inc. (RVMD)'s RAS(ON) Platform in Coverage Initiation [Yahoo! Finance]
3/29
07:23 pm
rvmd
Is Revolution Medicines, Inc. (RVMD) A Good Stock To Buy Now? [Yahoo! Finance]
Low
Report
Is Revolution Medicines, Inc. (RVMD) A Good Stock To Buy Now? [Yahoo! Finance]
3/27
08:05 pm
rvmd
Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Low
Report
Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
3/26
05:49 am
rvmd
Revolution Medicines (RVMD) was upgraded by Truist Financial Corporation to "strong-buy".
Low
Report
Revolution Medicines (RVMD) was upgraded by Truist Financial Corporation to "strong-buy".
3/19
02:44 pm
rvmd
Revolution, Ascendis, Arrowhead among RBC's top M&A candidates in biotech [Seeking Alpha]
Low
Report
Revolution, Ascendis, Arrowhead among RBC's top M&A candidates in biotech [Seeking Alpha]
3/17
07:18 pm
rvmd
Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting [Yahoo! Finance]
Low
Report
Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting [Yahoo! Finance]
3/17
06:37 pm
rvmd
Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
Low
Report
Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
3/16
10:58 am
rvmd
Revolution Medicines (RVMD) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Low
Report
Revolution Medicines (RVMD) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
3/8
03:23 am
rvmd
A Look At Revolution Medicines (RVMD) Valuation After Recent Share Price Momentum [Yahoo! Finance]
Low
Report
A Look At Revolution Medicines (RVMD) Valuation After Recent Share Price Momentum [Yahoo! Finance]
3/5
02:30 pm
rvmd
This One Data Readout Could Make Or Break Revolution Medicines [Seeking Alpha]
Low
Report
This One Data Readout Could Make Or Break Revolution Medicines [Seeking Alpha]
3/3
11:57 am
rvmd
Revolution Medicines, Inc. (RVMD) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Low
Report
Revolution Medicines, Inc. (RVMD) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
3/2
04:10 am
rvmd
Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs [Yahoo! Finance]
Low
Report
Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs [Yahoo! Finance]
2/27
08:44 am
rvmd
Revolution Medicines (RVMD) is now covered by UBS Group AG. They set a "buy" rating and a $145.00 price target on the stock.
Low
Report
Revolution Medicines (RVMD) is now covered by UBS Group AG. They set a "buy" rating and a $145.00 price target on the stock.
2/27
12:00 am
rvmd
Evercore ISI Initiates Revolution Medicines (RVMD) With an Outperform Rating – Here's Why [Yahoo! Finance]
Low
Report
Evercore ISI Initiates Revolution Medicines (RVMD) With an Outperform Rating – Here's Why [Yahoo! Finance]
2/26
11:52 am
rvmd
Revolution Medicines (RVMD) had its price target raised by Wells Fargo & Company from $100.00 to $144.00. They now have an "overweight" rating on the stock.
Low
Report
Revolution Medicines (RVMD) had its price target raised by Wells Fargo & Company from $100.00 to $144.00. They now have an "overweight" rating on the stock.
2/26
11:52 am
rvmd
Revolution Medicines (RVMD) had its price target raised by Piper Sandler from $75.00 to $120.00. They now have an "overweight" rating on the stock.
Low
Report
Revolution Medicines (RVMD) had its price target raised by Piper Sandler from $75.00 to $120.00. They now have an "overweight" rating on the stock.
2/26
08:20 am
rvmd
Revolution Medicines (RVMD) had its price target lowered by Needham & Company LLC from $150.00 to $145.00. They now have a "buy" rating on the stock.
Medium
Report
Revolution Medicines (RVMD) had its price target lowered by Needham & Company LLC from $150.00 to $145.00. They now have a "buy" rating on the stock.
2/26
08:17 am
rvmd
Has Revolution Medicines (RVMD) Found a Breakthrough in Cancer Treatment? [Yahoo! Finance]
Medium
Report
Has Revolution Medicines (RVMD) Found a Breakthrough in Cancer Treatment? [Yahoo! Finance]
2/26
06:28 am
rvmd
Revolution Medicines (RVMD) was upgraded by Evercore Inc to "strong-buy".
Medium
Report
Revolution Medicines (RVMD) was upgraded by Evercore Inc to "strong-buy".
2/26
12:42 am
rvmd
Revolution Medicines Inc (RVMD) Q4 2025 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Medium
Report
Revolution Medicines Inc (RVMD) Q4 2025 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
2/25
06:41 pm
rvmd
Revolution Medicines (RVMD) Earnings Transcript [Yahoo! Finance]
Low
Report
Revolution Medicines (RVMD) Earnings Transcript [Yahoo! Finance]
2/25
04:02 pm
rvmd
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
Low
Report
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress